Micro-RNA 21Targets Dual Specific Phosphatase 8 to Promote Collagen Synthesis in High Glucose-Treated Primary Cardiac Fibroblasts

Canadian Journal of Cardiology

Volumn 30, Issue 12, 2014, Pages 1689-1699

  Liu, Shulei ^a   Li, Wenqi ^a   Xu, Mingtong ^a   Huang, Hui ^a   Wang, Jingfeng ^a   Chen, Xiaochao ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b People's Hospital of Zengcheng   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; DUAL SPECIFICITY PHOSPHATASE; DUAL SPECIFICITY PHOSPHATASE 8; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE P38; PROCOLLAGEN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; COLLAGEN; MICRORNA; MIRN21 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; ENZYME ACTIVATION; FIBROBLAST; GENE EXPRESSION; HEART MUSCLE CELL; NONHUMAN; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUSCLE CELL; NEWBORN; PATHOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC CARDIOMYOPATHIES; FIBROBLASTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLUCOSE; MICRORNAS; MUSCLE CELLS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84919769860     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.07.747     Document Type: Article

References (34)

1. Aneja A., Tang W.H., Bansilal S., Garcia M.J., Farkouh M.E. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 2008, 121:748-757.
2. Krenning G., Zeisberg E.M., Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. JCell Physiol 2010, 225:631-637.
3. Brown R.D., Ambler S.K., Mitchell M.D., Long C.S. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Ann Rev Pharmacol Toxicol 2005, 45:657-687.
4. Roy S., Khanna S., Hussain S.R., et al. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 2009, 82:21-29.
5. Duisters R.F., Tijsen A.J., Schroen B., et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs inmyocardial matrix remodeling. Circ Res 2009, 104:170-178. 6p following178.
6. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
7. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
8. Bauersachs J. Regulation of myocardial fibrosis by MicroRNAs. JCardiovasc Pharmacol 2010, 56:454-459.
9. van Rooij E., Sutherland L.B., Thatcher J.E., et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008, 105:13027-13032.
10. Matkovich S.J., Wang W., Tu Y., et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 2010, 106:166-175.
11. Thum T., Gross C., Fiedler J., et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 2008, 456:980-984.
12. Shen E., Diao X., Wang X., Chen R., Hu B. MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy. Am J Pathol 2011, 179:639-650.
13. Cardin S., Guasch E., Luo X., et al. Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure. Circ Arrhythm Electrophysiol 2012, 5:1027-1035.
14. Feng B., Chen S., George B., Feng Q., Chakrabarti S. miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev 2010, 26:40-49.
15. Coqueret O. Linking cyclins to transcriptional control. Gene 2002, 299:35-55.
16. Camps M., Nichols A., Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 2000, 14:6-16.
17. Fan D., Takawale A., Lee J., Kassiri Z. Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 2012, 5:15.
18. Kondoh K., Nishida E. Regulation of MAP kinases by MAP kinase phosphatases. Biochim Biophys Acta 2007, 1773:1227-1237.
19. Chaturvedi R.R., Herron T., Simmons R., et al. Passive stiffness of myocardium from congenital heart disease and implications for diastole. Circulation 2010, 121:979-988.
20. Liang H., Zhang C., Ban T., et al. Anovel reciprocal loop between microRNA-21 and TGFbetaRIII is involved in cardiac fibrosis. Int J Biochem Cell Biol 2012, 44:2152-2160.
21. Liu G., Friggeri A., Yang Y., et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. JExp Med 2010, 207:1589-1597.
22. Zhang Z., Peng H., Chen J., et al. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice. FEBS Lett 2009, 583:2009-2014.
23. Dey N., Ghosh-Choudhury N., Kasinath B.S., Choudhury G.G. TGFbeta-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signalling for mesangial cell hypertrophy and matrix expansion. PloS One 2012, 7:e42316.
24. Villar A.V., Garcia R., Merino D., et al. Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients. Int J Cardiol 2013, 167:2875-2881.
25. Ji R., Cheng Y., Yue J., et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 2007, 100:1579-1588.
26. Lin Y., Liu X., Cheng Y., et al. Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. JBiol Chem 2009, 284:7903-7913.
27. Cheng Y., Liu X., Zhang S., et al. MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. JMol Cell Cardiol 2009, 47:5-14.
28. Li S., Liang Z., Xu L., Zou F. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases. Mol Cell Biochem 2012, 360:147-158.
29. van Rooij E. The art of microRNA research. Circ Res 2011, 108:219-234.
30. Cotsiki M., Oehrl W., Samiotaki M., Theodosiou A., Panayotou G. Phosphorylation of the M3/6 dual-specificity phosphatase enhances the activation of JNK by arsenite. Cell Signal 2012, 24:664-676.
31. Hink R.L., Hokanson J.E., Shah I., et al. Investigation of DUSP8 and CALCA in alcohol dependence. Addict Biol 2003, 8:305-312.
32. Cargnello M., Roux P.P. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 2011, 75:50-83.
33. Goldberg H., Whiteside C., Fantus I.G. O-linked beta-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells. Am J Physiol Endocrinol Metab 2011, 301:E713-E726.
34. Tang M., Zhang W., Lin H., et al. High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2. Mol Cell Biochem 2007, 301:109-114.